Indeed, in LSCC, the ECM degradation is activated during the progression from early stage to middle stage LSCC, indicating that cancer cells of LSCC can secret ECM degradation-associated protein MMP-2 to promote their invasive ability. This evidence concerns the gene MMP2 and cancer.